Skip to main content

Table 2 Ethnic differences in the infectious burden and the prevalence of infections

From: Ethnic differences in infectious burden and the association with metabolic risk factors for cardiovascular disease: a cross-sectional analysis

 

Crude prevalence

Age and sex adjusted OR (95%-CI)

 

Dutch (n = 440)

Moroccan (n = 272)

Turkish (n = 320)

Moroccan versus Dutch

Turkish versus Dutch

IB

-High

38 (8.6)

103 (37.9)

138 (41.1)a

7.0 (4.6–10.8)b

10.8 (7.0–16.5)b

-Intermediate

110 (25.0)

155 (57.0)

165 (51.6)

  

-Low

292 (66.4)

14 (5.1)

17 (5.3)

  

HSV1 positive

281 (63.9)

269 (98.9)

308 (96.3)a

60.5 (18.9–193.3)

19.0 (10.2–35.5)

HSV2 positive

100 (22.7)

43 (15.8)

35 (10.9)a

0.68 (0.45–1.0)

0.45 (0.30–0.69)

HAV positive

217 (49.3)

261 (96.0)

310 (96.9)a

35.6 (18.4–69.2)

22.2 (27.6–110.5)

HBV positive

25 (5.7)

77 (28.3)

120 (37.5)a

6.8 (4.1–11.2)

13.6 (8.3–22.2)

HCV positive

1 (0.2)

1 (0.4)

0 (0)

H.pylori positive

252 (57.3)

267 (98.2)

313 (97.8)a

46.5 (18.6–116.0)

44.6 (20.2–98.2)

  1. Data are given as n (%) or as median (minimum-maximum), IB infectious burden measured by the number of infections (HSV1, HSV2, HAV, HBV, HCV and H.pylori) a participant was seropositive for. With the term infection we in this study refer to antibody seropositivity, a measure reflecting current or past infection. The subcategories are: low (0–2 infections), intermediate (3 infections) and high (4–6 infections); HSV1 herpes simplex virus 1, HSV2 herpes simplex virus 2, HAV hepatitis virus A, HBV hepatitis virus B, HCV hepatitis virus C, H.pylori Helicobacter pylori, OR odds ratio, CI confidence interval, a p-value univariate comparison < 0.001, b Comparison made between high IB and other